Skip to main content
RecallRadar
FDAClass III

Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactur… Recalled: Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifica…

Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg,… was recalled on October 1, 2026 in cooperation with the U.S. Food and Drug Administration because superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications.

Is my unit affected?

Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.

Model, lot & date codes to check

Lot # 3228113, 3228114, 3228115, Exp Date: Oct 31, 2026; Lot # 3228120, 3228121, Exp Date: Nov 30, 2026.

Units affected: 21,620 30-count bottles

Where it was sold: Nationwide in the USA.

Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.

What's the hazard?

Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications

Class III means the product is unlikely to cause a health problem, but it violates FDA labeling or manufacturing rules.

Your remedy & how to claim it

Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.

Contact: Recalling firm: Viatris, Inc.

Not sure what you're entitled to? Read our guide: what to do if your product is recalled.

Official recall notice

Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.

View official notice →

Get recall alerts

Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.

Double opt-in: we only email you after you confirm. No spam, ever.